Enzira product information

This site has been optimised for usage with Internet Explorer 7 or higher.

It appears you may be using an earlier version than IE7 in which case some features may not display or may display error messages. You can upgrade your internet browser for free on the following links, this will allow you to fully explore the Pfizer Vaccines website.

Mozilla Firefox

Google Chrome

Internet Explorer 8

No, thanks, just continue.

I hereby confirm that I am a healthcare professional practising in the UK.

I accept Pfizer's Privacy Policy & Terms and Conditions.

Home HCP > Protect > Products > Enzira product information

Enzira product information

Enzira® Suspension for injection pre-filled syringe/Influenza vaccine (split virion, inactivated) PH. Eur

Each 0.5 ml dose contains 15 micrograms of each of three purified influenza virus antigens prepared from the strains of influenza virus that comply with the WHO recommendations (northern hemisphere) and EU decision for the current season.

A/California/7/2009 (H1N1)-like strain (A/California/7/2009 NYMC X-181)
A/Perth/16/2009 (H3N2)-like strain (A/Victoria/210/2009/ NYMC X-187)
B/Brisbane/60/2008-like strain (B/Brisbane/60/2008)

Immunisation should be carried out by intramuscular or deep subcutaneous injection.

Summary of Product Characteristics can be found on electronic Medicines Compendium (eMC) click here to view.

Influenza

Influenza is an acute viral infection of the respiratory tract that affects the upper airways and lungs and is highly infectious with a usual incubation period of one to three days...